PAR paradigm biopharmaceuticals limited..

The Ghosh Study - PART 1, page-13

  1. 5,000 Posts.
    lightbulb Created with Sketch. 532
    Pain is subjective, and success depends on individual perception, making investment in these areas inherently risky. As a result they may choose to wait rather than invest early, even if it means higher costs later.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
31.0¢
Change
0.020(6.90%)
Mkt cap ! $120.7M
Open High Low Value Volume
29.0¢ 31.0¢ 28.0¢ $97.62K 331.4K

Buyers (Bids)

No. Vol. Price($)
2 74197 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 54675 2
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.